Research
Craniofacial Hyperhidrosis (Facial Sweating): The Data
Craniofacial hyperhidrosis, excessive sweating of the face, forehead, and scalp, is a focal subtype of primary hyperhidrosis. It stands out in the data for one reason above all: it begins later in life than any other focal site, with a mean age of onset of about 25 years versus around 11 years for palms and soles. It is the predominant site in roughly 5% of primary hyperhidrosis cases, though a much larger share of people with hyperhidrosis report at least some facial involvement. This page compiles the verified epidemiology, with every figure traced to its source. It is general education, not a diagnosis.
By the Sweat Explained Editorial Team · Published 2026-07-13 · Last reviewed 2026-07-13 · Educational information, not medical advice.
Key statistics at a glance
~25.4 yrs
mean age of onset for craniofacial hyperhidrosis, the latest of any focal site
Walling 2009 (n=387)
5.2%
of primary hyperhidrosis patients had craniofacial as the predominant site
Walling 2009 (n=387)
42%
of US adults with hyperhidrosis reported head/face as an affected area
Doolittle 2016 (n=393 with HH)
~93%
of all hyperhidrosis is primary; craniofacial is one of its typical focal sites
Nawrocki & Cha 2019 review
What craniofacial hyperhidrosis is
Primary focal hyperhidrosis is excessive, roughly symmetric sweating that exceeds the body's thermoregulatory needs and has no underlying medical cause. It clusters at characteristic sites: the underarms, palms, soles, and the craniofacial region: the face, forehead, and scalp. In a large review, about 93% of people with hyperhidrosis have the primary form, and more than 90% of those show this typical focal, bilateral pattern (Nawrocki & Cha 2019).
Craniofacial hyperhidrosis is the facial and scalp expression of that pattern. Because sweating is so visible on the face, it is often reported as socially conspicuous, but in the epidemiology it is one of the less common predominant sites, while being a very common secondary area in people whose main problem is elsewhere.
Facial sweating starts later than any other focal site
In a retrospective review of 387 primary hyperhidrosis patients seen at a US academic center (1993–2005), the mean age of onset varied sharply by anatomic site. Palms and soles typically began in childhood; the craniofacial site began, on average, in the mid-twenties, the latest of any focal distribution.
| Group | Value |
|---|---|
| Palmoplantar | 11.5 yrs (±8.0) |
| All sites (overall) | 18.6 yrs (±12.3) |
| Axillary | 20 yrs (±8.3) |
| Craniofacial | 25.4 yrs (±13.7) |
Source: Walling HW, J Am Acad Dermatol 2009. Chart is an original rendering of the cited data.
Why the later onset matters
The later average onset is not a trivial detail. Palmoplantar and axillary hyperhidrosis commonly begin in childhood or adolescence, whereas a craniofacial pattern first appearing in adulthood is worth a clinician's attention, because new-onset facial or head sweating in an adult can also be a feature of secondary causes (for example, gustatory sweating, endocrine conditions, or medication effects) rather than primary hyperhidrosis. The averages describe primary cases; they are not a rule that facial sweating is always primary.
Anyone with facial or scalp sweating that is new, one-sided, tied to eating, or accompanied by other symptoms is generally advised to see a clinician, who can distinguish primary focal hyperhidrosis from a secondary cause.
Predominant site vs. any involvement
Two different questions give two very different numbers. When a patient's single predominant site is recorded, craniofacial is relatively uncommon. When people with hyperhidrosis are asked which areas are affected at all, allowing multiple answers, head/face is reported far more often. Both figures below are verified; they simply measure different things.
| Measure | Figure | Source |
|---|---|---|
| Craniofacial as the predominant focal site | 5.2% | Walling 2009 |
| Head/face reported as an affected area (multi-select) | 42% | Doolittle 2016 |
| Underarms reported as an affected area (for comparison) | 65% | Doolittle 2016 |
Walling records one predominant site per patient; Doolittle's survey let respondents with hyperhidrosis select every affected area, so its percentages sum to more than 100%.
How common is hyperhidrosis overall?
For context, a nationally representative US survey of 8,160 people estimated that about 4.8% of the population, roughly 15.3 million people, has hyperhidrosis, and 70% of those affected reported severe sweating in at least one body area (Doolittle 2016). Yet only about 51% had ever discussed it with a healthcare professional. Craniofacial hyperhidrosis is a subset of this larger group, defined by where the sweating is concentrated rather than by a separate prevalence survey.
Why the face is a harder site to manage
Facial and scalp sweating is generally considered more difficult to address than sweating at other sites, for practical reasons rather than any single statistic. Topical products are awkward to apply to the face and around the eyes; the region is highly visible; and the many small muscles of facial expression sit directly beneath the treatment area. Because of this, published treatment reviews discuss craniofacial hyperhidrosis as a distinct management challenge (Nawrocki & Cha 2019).
This page does not rank or recommend treatments. Anyone bothered by facial sweating is best served by discussing options with a qualified clinician, who can weigh the trade-offs for this particular site.
Methodology and limitations
This page draws on a single-center retrospective case series of 387 primary hyperhidrosis patients (Walling 2009) for site-specific onset and distribution; a nationally representative US survey (Doolittle 2016) for population prevalence and self-reported affected areas; and a peer-reviewed review (Nawrocki & Cha 2019) for the primary-vs-secondary split and the description of typical focal sites. Each figure was traced to its source and confirmed.
Limitations: the onset and 5.2% distribution figures come from one academic referral center, which may not represent the general population; referral samples can over- or under-represent particular sites. The 42% and 65% figures are self-reported and allow multiple affected areas, so they are not directly comparable to the 5.2% predominant-site figure. All onset ages are means with wide standard deviations, so individual experience varies greatly. Nothing here is a diagnosis or medical advice; new or one-sided facial sweating should be assessed by a clinician.
Frequently asked questions
- At what age does craniofacial hyperhidrosis usually start?
- On average around 25 years, the latest onset of any focal site. By comparison, palmoplantar hyperhidrosis begins on average near 11 years and axillary near 20 years (Walling 2009). These are means with wide variation, so individual onset differs.
- How common is facial hyperhidrosis?
- It depends on how you count. Craniofacial was the single predominant site in 5.2% of 387 primary hyperhidrosis patients (Walling 2009), but 42% of US adults with hyperhidrosis reported head/face as an affected area when allowed to select multiple sites (Doolittle 2016).
- Is facial sweating usually primary or secondary?
- Most hyperhidrosis overall is primary (about 93%; Nawrocki & Cha 2019). But new-onset, one-sided, or eating-triggered facial sweating in an adult can indicate a secondary cause, so it is worth having assessed by a clinician.
- Why is facial sweating harder to treat than underarm sweating?
- For practical reasons: the face is highly visible, topical products are difficult to apply near the eyes, and the small muscles of facial expression lie just beneath the skin. Published reviews treat craniofacial hyperhidrosis as a distinct management challenge (Nawrocki & Cha 2019).
- How many people have hyperhidrosis in general?
- A US survey estimated about 4.8% of the population, roughly 15.3 million people, with 70% of them reporting severe sweating in at least one area, yet only 51% had discussed it with a healthcare professional (Doolittle 2016).
Sources
Primary peer-reviewed studies and official sources first, then reviews and institutional framing (secondary).
- Walling HW. Primary hyperhidrosis increases the risk of cutaneous infection: a case-control study of 387 patients. J Am Acad Dermatol. 2009;61(2):242–246. PMID 19395123 (site-specific onset and distribution data). PubMed
- Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: A comprehensive review (Part I: Etiology and clinical work-up). J Am Acad Dermatol. 2019;81(3):657–666. PMID 30710604. PubMed
- Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res. 2016;308(10):743–749 (survey of 8,160; 393 with HH). Full text
How to cite this page
Sweat Explained. Craniofacial Hyperhidrosis (Facial Sweating): The Data. Published 2026-07-13; last reviewed 2026-07-13. Available at: https://sweatexplained.com/research/craniofacial-hyperhidrosis-statistics
Please cite the original studies for the underlying figures. Journalists are welcome to link to this page; the charts are original renderings of the cited data.